Showing results (491-500 of 522) with videos related to

Sort By:
Pageof 53
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|March 24, 2023
Use of expert consensus to develop a shared list of procedures with potential for aerosol generation during the coronavirus disease 2019 (COVID-19) pandemicDana E Pepe, Preeti Mehrotra, Lou Ann Bruno-Murtha, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2016
Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US HospitalsSameer S Kadri, Bruce J Swihart, Stephanie L Bonne, et al.
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
La Clinica Terapeutica|August 12, 2006
Circadian distribution of hematology variables in subjects with multiple sclerosisE L Kanabrocki, D L Vesely, R C Hermida, et al.
Plos One|December 3, 2010
Helicobacter pylori from Peruvian amerindians: traces of human migrations in strains from remote Amazon, and genome sequence of an Amerind strainDangeruta Kersulyte, Awdhesh Kalia, Robert H Gilman, et al.
Infection Control and Hospital Epidemiology|February 29, 2020
Community-acquired in name only: A cluster of carbapenem-resistant Acinetobacter baumannii in a burn intensive care unit and beyondErica S Shenoy, Virginia M Pierce, Mohamad R A Sater, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2018
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line AgentsSameer S Kadri, Jennifer Adjemian, Yi Ling Lai, et al.
The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.
Open Forum Infectious Diseases|August 11, 2022
Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United StatesWilfredo R Matias, Jacob M Koshy, Ellen H Nagami, et al.
Plos One|August 8, 2012
Socioeconomic and nutritional factors account for the association of gastric cancer with Amerindian ancestry in a Latin American admixed populationLatife Pereira, Roxana Zamudio, Giordano Soares-Souza, et al.
Pageof 53